PEARCE CATHERINE (Chief Operating Officer) received a stock award from CINCOR PHARMA, INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 1/30/2023ACC: 0001209191-23-005593
Officer· Chief Operating Officer
Since Jan 2022
+15K
Net shares
Net buyer
$0.00
Total acquired
0
Open market trades
0B · 0S
1
Total transactions
15K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+15K
Price / share
—
Trade value
—
% of position
10.7%
1/26/2023
140.15K→155.15K
Total
Net shares
+15K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 1/26/2023 | A · Award | +15K | — | — | 10.7% | 140.15K | 155.15K |
| Total | +15K | $0.00 | ||||||
Derivative Transactions0
No derivative transactions reported
Non-Derivative Holdings (Post-Transaction)1
Common Stock
IndirectShares owned1.50K
Total
1.50K indirect1.50K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 1.50K | Indirect |
| Total | 1.50K | 1.50K indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported